Clin2
NCT06762743Likely a fitEnrolling by invitation

Comparing two brivaracetam oral solutions in healthy adults

Epilepsy (treatment Refractory)

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests whether two different forms of an oral solution of brivaracetam (a seizure medication) have the same effect in the body. Healthy adults take one dose and have blood samples collected—first on an empty stomach, and later after a high-fat meal—to compare how the drug is absorbed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Be between 18 and 55 years old
  • Be generally healthy with no major illnesses
  • Not smoke more than 5 cigarettes a day or chew betel nut regularly
  • Not have taken any prescription or over-the-counter medications in the last 2 weeks
  • Have no known allergies to the study drug or its ingredients

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT04715646Recruiting· Phase 3
Brivaracetam study for children with hard-to-control seizures

This trial looks at how safe brivaracetam is and how well it can be used in children and teens with certain types of epilepsy that are not well controlled. It may help families who are dealing with frequent focal seizures despite taking seizure medicines.

Hawthorne, New York
NCT07421401Not yet recruiting· Phase 1
Study of BR1015-A and BR1015 drugs in healthy adults

This trial tests how the body processes a new drug combination (BR1015-A vs. BR1015-3 and BR1015-2 taken together) in healthy volunteers. It helps researchers understand the safety and drug levels in the blood when taken on an empty stomach.

NCT07421388Not yet recruiting· Phase 1
Study of BR1015-A and its components under fed conditions

This trial tests a new medicine called BR1015-A. It compares how the body handles the medicine when given alone versus as two separate parts taken together. The study is done after eating to see how food affects the drug.

NCT07421414Not yet recruiting· Phase 1
Study of a new drug taken with food in healthy volunteers

This trial tests a new medicine (BR1015-A) taken with food and compares it to taking two other medicines together. It is for healthy volunteers to see how the drug moves through the body and if it is safe.

NCT07421375Not yet recruiting· Phase 1
Study of BR1015 drug levels and safety in healthy adults

This trial tests a new drug, BR1015, to see how it moves through the body and if it is safe. It is for healthy adults who are willing to fast before taking the medicine.

Hear when a new Epilepsy (Treatment Refractory) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.